"Located in Pottstown, PA, and a member of Tower Health, Pottstown Hospital is a 219-bed hospital that offers a full range of health services, including inpatient and outpatient, medical and surgical, and diagnostic and emergency care. Pottstown Hospital is accredited by The Joint Commission and has been recognized for its quality outcomes and clinical expertise across many service lines. Its cancer program is nationally recognized. The hospital also is a Primary Stroke Center; Joint Commission-certified for hip and knee replacement; and Heart Failure and Chest Pain certified. Its Emergency Room, which is the second busiest in Montgomery County, sees more than 40,000 patients a year."

During the past decade, Pottstown Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 40 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 23 clinical trials were completed. i.e. 121.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pottstown Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "AmpliMed Corporation" with 7 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pottstown Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Pottstown Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Pottstown Hospital" in a lesser frequency.

Most popular intervention types in "Pottstown Hospital" are "Drug" (68 trials), "Other" (52 trials), "Biological" (39 trials), "Procedure" (12 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (15 trials), "Paclitaxel" (13 trials), "Docetaxel" (10 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Pottstown Hospital" are 75 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Pottstown Hospital". undefined are not yet recruiting, 17 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Pottstown Hospital, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Pottstown Hospital, 0 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".